196 related articles for article (PubMed ID: 1684503)
1. Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site.
Ikeguchi M; Teeter LD; Eckersberg T; Ganapathi R; Kuo MT
DNA Cell Biol; 1991 Nov; 10(9):639-49. PubMed ID: 1684503
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Chinese hamster P-glycoprotein/multidrug resistance gene pgp1 reveals that the AP-1 site is essential for full promoter activity.
Teeter LD; Eckersberg T; Tsai Y; Kuo MT
Cell Growth Differ; 1991 Sep; 2(9):429-37. PubMed ID: 1661134
[TBL] [Abstract][Full Text] [Related]
3. Two proximal activating protein-1-binding sites are sufficient to stimulate transcription of the ovine follicle-stimulating hormone-beta gene.
Strahl BD; Huang HJ; Pedersen NR; Wu JC; Ghosh BR; Miller WL
Endocrinology; 1997 Jun; 138(6):2621-31. PubMed ID: 9165057
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the AP-1 sites in the IL-2 promoter.
Jain J; Valge-Archer VE; Rao A
J Immunol; 1992 Feb; 148(4):1240-50. PubMed ID: 1737937
[TBL] [Abstract][Full Text] [Related]
6. Identification of two nuclear protein binding sites and their role in the regulation of the murine multidrug resistance mdr1a promoter.
Cohen D; Yu L; Rzepka R; Horwitz SB
DNA Cell Biol; 1994 Jun; 13(6):641-9. PubMed ID: 7912938
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of the mouse mdr3 gene coincides with the appearance of novel transcription initiation sites in multidrug-resistant P388 tumor cells.
Lepage P; Raymond M; Nepveu A; Gros P
Cancer Res; 1993 Apr; 53(7):1657-64. PubMed ID: 8453638
[TBL] [Abstract][Full Text] [Related]
8. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the promoter region of the human MDR3 P-glycoprotein gene.
Smit JJ; Mol CA; van Deemter L; Wagenaar E; Schinkel AH; Borst P
Biochim Biophys Acta; 1995 Mar; 1261(1):44-56. PubMed ID: 7893760
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a hepatoma cell-specific enhancer in the mouse multidrug resistance mdr1b promoter.
Song R; Ikeguchi M; Zhou G; Kuo MT
J Biol Chem; 1995 Oct; 270(43):25468-74. PubMed ID: 7592715
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characterization of the mouse multidrug resistance gene family.
Dhir R; Buschman E; Gros P
Bull Cancer; 1990; 77(11):1125-9. PubMed ID: 1980424
[TBL] [Abstract][Full Text] [Related]
12. Activation of a MMTV/mdr3 fusion transcript from a cryptic viral promoter is stimulated by mdr-derived sequences located in intron I.
Lepage P; Underhill DA; Gros P
Virology; 1995 Jul; 210(2):244-53. PubMed ID: 7618265
[TBL] [Abstract][Full Text] [Related]
13. A novel cis-acting element is involved in the promoter activity of the rat mdr1b gene.
Zhou G; Song R; Kuo MT
Cell Growth Differ; 1996 Oct; 7(10):1369-81. PubMed ID: 8891341
[TBL] [Abstract][Full Text] [Related]
14. Identification of a 10-base pair protein binding site in the promoter of the hamster H3.2 gene required for the S phase dependent increase in transcription and its interaction with a Jun-like nuclear factor.
Naeve GS; Sharma A; Lee AS
Cell Growth Differ; 1992 Dec; 3(12):919-28. PubMed ID: 1472472
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional analysis of the regulatory sequences of the ets-1 gene.
Oka T; Rairkar A; Chen JH
Oncogene; 1991 Nov; 6(11):2077-83. PubMed ID: 1945412
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
Salbert G; Fanjul A; Piedrafita FJ; Lu XP; Kim SJ; Tran P; Pfahl M
Mol Endocrinol; 1993 Oct; 7(10):1347-56. PubMed ID: 8264664
[TBL] [Abstract][Full Text] [Related]
17. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells.
Zhao JY; Ikeguchi M; Eckersberg T; Kuo MT
Endocrinology; 1993 Aug; 133(2):521-8. PubMed ID: 8102093
[TBL] [Abstract][Full Text] [Related]
18. Proximal promoter of the surfactant protein D gene: regulatory roles of AP-1, forkhead box, and GT box binding proteins.
He Y; Crouch EC; Rust K; Spaite E; Brody SL
J Biol Chem; 2000 Oct; 275(40):31051-60. PubMed ID: 10915785
[TBL] [Abstract][Full Text] [Related]
19. Three distinct nuclear protein binding sites in the promoter of the murine multidrug resistance mdr1b gene.
Yu L; Cohen D; Piekarz RL; Horwitz SB
J Biol Chem; 1993 Apr; 268(10):7520-6. PubMed ID: 8096513
[TBL] [Abstract][Full Text] [Related]
20. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene.
Lengyel E; Wang H; Stepp E; Juarez J; Wang Y; Doe W; Pfarr CM; Boyd D
J Biol Chem; 1996 Sep; 271(38):23176-84. PubMed ID: 8798512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
